Catalyst Wire Dossier Catalyst Wire Dossier

Normal Human Immunoglobulins (IVIG)

intravenous immunoglobulin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Normal Human Immunoglobulins (IVIG), covering 2020-05-27 to 2020-05-27. Get the full timeline:

Most recent: Clinical Trial Update: NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE [Phase 2]

See pricing